All News
STAT+: Scientists are pushing to get their grants reinstated — and some are winning
The grant termination letters say there are no appeals. Yet dozens of appeals have succeeded as biomedical researchers lobby and sue to restore funding.
Read MoreOpinion: The end to animal testing marks the beginning of better biomedicine
No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough options for the humans that need them.
Read MoreOpinion: There is no replacement (yet) for animal models in medical research
The NIH is “reducing animal use in research.” But there is no replacement for animal models.
Read MoreThe role of nanotechnology in precision surgery
Dr Manas Ranjan Tripathy highlights how nanotechnology is shaping the future of precision surgery, from targeted drug delivery to post-operative care advancements
Read MoreAttacks on healthcare in war zones in 2024 reach ‘new levels of horror’ – report
Health facilities were destroyed and staff killed in record numbers in conflicts in Gaza, Lebanon, Ukraine, Myanmar and SudanLast year saw more than 3,600 attacks on health workers, hospitals and clin
Read MoreSpring Night review – elliptical tale of Korean lovers is study of elemental passion
After meeting at a wedding, Su-hwan and Yeong-gyeong plunge into a desperate relationship fuelled by alcohol, and powered by tremendous performancesSeventeen years after her debut feature Let the Blue
Read MoreFDA approves first blood test to support Alzheimer’s diagnosis
The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood test
Read MoreJoe Biden Is Diagnosed With an Aggressive Form of Prostate Cancer
The cancer has metastasized to the bone, according to a statement from Mr. Biden’s personal office.
Read MoreWhat a Prostate Cancer Diagnosis Like Biden’s Means for Patients
While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now improve survival by years.
Read MorePalopegteriparatide Benefits Sustained in Adults With Chronic Hypoparathyroidism
(MedPage Today) -- ORLANDO -- Palopegteriparatide (Yorvipath) led to sustained improvements over 2 years in adults with chronic hypoparathyroidism, according to long-term phase III PaTHway trial re
Read More